1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone
C34H31N5O2 — CID 155796212
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone
1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone (PubChem CID 155796212) has the molecular formula C34H31N5O2 and a molecular weight of 541.66 g/mol. Its IUPAC name is 1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone.
Molecular Properties
| Compound Name | 1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone |
|---|---|
| PubChem CID | 155796212 |
| Molecular Formula | C34H31N5O2 |
| Molecular Weight | 541.66 g/mol |
| Exact Mass | 541.25 |
| IUPAC Name | 1-[4-benzyl-2-(5-naphthalen-2-yl-1H-imidazol-2-yl)piperazin-1-yl]-2-(5-hydroxy-1H-indol-3-yl)ethanone |
| SMILES | O=C(Cc1c[nH]c2ccc(O)cc12)N1CCN(Cc2ccccc2)CC1c1ncc(-c2ccc3ccccc3c2)[nH]1 |
| InChI | InChI=1S/C34H31N5O2/c40-28-12-13-30-29(18-28)27(19-35-30)17-33(41)39-15-14-38(21-23-6-2-1-3-7-23)22-32(39)34-36-20-31(37-34)26-11-10-24-8-4-5-9-25(24)16-26/h1-13,16,18-20,32,35,40H,14-15,17,21-22H2,(H,36,37) |
| InChIKey | BETHYFHVWIJKPV-UHFFFAOYSA-N |
| XLogP | 6.05 |
| TPSA | 88.25 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 541.66 |
| LogP ≤ 5 | 6.05 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155796212 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.